new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Metabolex Inc patents

Recent patent applications related to Metabolex Inc. Metabolex Inc is listed as an Agent/Assignee. Note: Metabolex Inc may have other listings under different names/spellings. We're not affiliated with Metabolex Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Metabolex Inc-related inventors




Date Metabolex Inc patents (updated weekly) - BOOKMARK this page
07/24/14Dcc mediated coupling for halofenate manufacture
05/08/14Methods for treating gout flares
05/08/14Methods for treating gout flares
05/01/14Gpr120 receptor agonists and uses thereof
02/06/14Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
01/23/14Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
01/23/14Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto
11/14/13Methods for treating gout in patients subpopulations
07/04/13Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent
05/23/13Gpr120 receptor agonists and uses thereof
05/02/13Gpr120 receptor agonists and uses thereof
03/07/13Bicyclic agonists of gpr131 and uses thereof
03/07/13Agonists of gpr131 and uses thereof
12/20/12N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
09/13/12Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
09/13/12Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto
09/06/12Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
07/19/12Aryl gpr119 agonists and uses thereof
12/29/11Compositions of 5-ethyl-2--pyrimidine
12/22/11Gpr120 receptor agonists and uses thereof
12/22/11Preparation of 5-ethyl-2--pyrimidine
12/01/11Aryl gpr119 agonists and uses thereof
06/30/11Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
06/23/11Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
08/26/10Aryl gpr120 receptor agonists and uses thereof
07/29/10Gpr120 receptor agonists and uses thereof
06/17/10Methods of reducing small, dense ldl particles
05/27/10Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
04/08/10Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
04/08/10Modulators of ppar and methods of their preparation
10/29/09Oxymethylene aryl compounds and uses thereof
05/28/09N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
04/09/09Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylamines
02/26/09Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Metabolex Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Metabolex Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';